If you place Pennsylvania workers' comp accounts and haven't looked at how pharmacy referrals flow through your clients' claims, a recent court decision should put it on your radar.
What the Pennsylvania Court Ruling Means for Rx Panels
A Pennsylvania court ruled that doctor-owned pharmacy referrals are permissible under the state's workers' comp framework, overturning what had been a significant barrier to physician-dispensed drug models in the system. The decision effectively allows treating physicians to direct prescriptions to pharmacies in which they hold an ownership interest, a practice that had previously drawn legal challenge. The full ruling is covered by Risk & Insurance.
This matters because physician-dispensed and self-referral pharmacy setups have historically carried higher average script costs compared with retail or PBM-managed channels. When the doctor dispensing the drug also profits from the fill, the incentive structure tilts toward higher-cost brand drugs, longer durations, and more frequent dispensing — all of which land on the employer's loss run.
Why It Matters for Your Placements
Pennsylvania's workers' comp medical costs have been under sustained pressure for years. A separate Risk & Insurance analysis flagged medical cost inflation as one of three structural threats reshaping the workers' comp landscape nationally, with prescription drug spend as a key component. The court ruling doesn't create a new cost driver out of thin air, but it removes a legal barrier that had been keeping one of the more expensive pharmacy channels in check in Pennsylvania.
For agents, the practical concern is that this ruling may encourage more physician groups to establish or expand owned-pharmacy arrangements, particularly in the occupational injury and orthopedic specialties that drive the largest share of workers' comp drug spend. If your client's claim panel funnels prescriptions through a physician-owned operation, the cost per claim can be meaningfully higher than a standard PBM arrangement — and that cost gets baked into the experience modification calculation at the next renewal cycle.
What I'm watching for in submissions: When this hits agent desks, the question I'd ask is whether the carrier's PBM contract already has guardrails around physician-dispensed pharmacies — or whether this ruling quietly opens the door to a cost channel nobody's tracking yet. That distinction matters at binding.
What to Do Right Now
1. Flag your PA accounts with active or recent pharmacy-heavy claims. Look at loss runs where medical makes up more than 60% of total incurred, and where Rx is a line item. Those are the accounts most vulnerable to self-referral cost creep.
2. Ask your carrier or PBM partner a direct question: Does the pharmacy network or panel for this account include any physician-dispensed or doctor-owned pharmacy arrangements? You don't need a legal opinion — you need a yes or no so you can document it.
3. Document the answer in your submission and renewal file. If the answer is yes, note it. If the carrier can't tell you, note that too. When the mod calculates in 18 months, you'll want a record of what was in the claims pipeline.
4. For new submissions in Pennsylvania, add a line to your underwriter cover letter asking whether the pharmacy panel includes self-referral channels. This signals diligence and gives the underwriter a chance to flag it before binding.
5. Watch for carrier responses. Some carriers may respond to this ruling by tightening their pharmacy panel criteria or adding disclosures. Others may stay silent. Either way, the agent who asked the question and documented the answer is in a better position at renewal than the one who didn't.
What This Means for Your Placements
This ruling won't reshape the Pennsylvania workers' comp market overnight, but it creates a slow-building cost pressure that agents can get ahead of now. The accounts most at risk are mid-size employers with higher-frequency injury profiles — manufacturing, warehousing, healthcare — where orthopedic and pain-management prescribing drives a large share of medical dollars.
If you're renewing a PA account in the next 90 days and you haven't asked about the pharmacy panel structure, do it before the submission goes out. It takes five minutes, it costs nothing, and it gives you a data point that most agents in the state won't have. In a market where medical costs are already climbing, that kind of documentation is what separates a defensible renewal from a surprise mod increase.
Sources
- Risk & Insurance (2026-06-22)
- Risk & Insurance (2026-06-18)
Tags: pennsylvania, pharmacy, medical-costs, doctor-owned-pharmacy, self-referral